<SEC-DOCUMENT>0001193125-18-004572-index.html : 20180105
<SEC-HEADER>0001193125-18-004572.hdr.sgml : 20180105
<ACCEPTANCE-DATETIME>20180105165303
ACCESSION NUMBER:		0001193125-18-004572
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20180103
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180105
DATE AS OF CHANGE:		20180105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		18513988

	BUSINESS ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d518825d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: d518825d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d518825dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
Document 2 - file: d518825dex11.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d518825dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: d518825dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d518825dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 4 - file: d518825dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>d518825dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 5 - file: d518825dex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g518825g0105105127407.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g518825g0105105127407.jpg

</DOCUMENT>
</SEC-DOCUMENT>